Get started
Author

Qingchun Huang

The oral and gut microbiomes are perturbed in rheumatoid arthritis and partly normalized after treatment
2015 · Xuan Zhang, Dongya Zhang, et al. · Nature Medicine · 1,689
Clinical Practice Guideline for Tripterygium Glycosides/Tripterygium wilfordii Tablets in the Treatment of Rheumatoid Arthritis
2021 · Na Lin, Yan-Qiong Zhang, et al. · Frontiers in Pharmacology · 127
PDF
Can active components of licorice, glycyrrhizin and glycyrrhetinic acid, lick rheumatoid arthritis?
2015 · Qing-Chun Huang, Mao-Jie Wang, et al. · Oncotarget · 101
PDF
Comparison of combination therapy with methotrexate and sinomenine or leflunomide for active rheumatoid arthritis: A randomized controlled clinical trial
2018 · Run-yue Huang, Hu-dan Pan, et al. · Phytomedicine · 81
PDF
Licochalcone A activates Keap1-Nrf2 signaling to suppress arthritis via phosphorylation of p62 at serine 349
2017 · Xiaohui Su, Ting Li, et al. · Free Radical Biology and Medicine · 79
Anti-inflammatory and Pro-apoptotic Effects of 18beta-Glycyrrhetinic Acid In Vitro and In Vivo Models of Rheumatoid Arthritis
2021 · Yunhui Feng, Liyan Mei, et al. · Frontiers in Pharmacology · 67
PDF
The Effectiveness and Safety of Tripterygium wilfordii Hook. F Extracts in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
2018 · Ying-Yan Zhou, Xuan Xia, et al. · Frontiers in Pharmacology · 66
PDF
18β-Glycyrrhetinic Acid Suppresses Cell Proliferation through Inhibiting Thromboxane Synthase in Non-Small Cell Lung Cancer
2014 · Run-Yue Huang, Yong-Liang Chu, et al. · PLoS ONE · 51
PDF
Chinese Herbal Medicines for Rheumatoid Arthritis: Text‐Mining the Classical Literature for Potentially Effective Natural Products
2020 · Xuan Xia, Brian H. May, et al. · Evidence-based Complementary and Alternative Medicine · 38
PDF
Identification of potential genetic causal variants for rheumatoid arthritis by whole-exome sequencing
2017 · Ying Li, Elaine Lai-Han Leung, et al. · Oncotarget · 37
Chinese Herbal Formula Huayu-Qiangshen-Tongbi Decoction Compared With Leflunomide in Combination With Methotrexate in Patients With Active Rheumatoid Arthritis: An Open-Label, Randomized, Controlled, Pilot Study
2020 · Jiaqi Wu, Xianghong Chen, et al. · Frontiers in Medicine · 23
PDF
Traditional Chinese Medicine Qingre Huoxue Treatment vs. the Combination of Methotrexate and Hydroxychloroquine for Active Rheumatoid Arthritis: A Multicenter, Double-Blind, Randomized Controlled Trial
2021 · Xun Gong, Wei-Xiang Liu, et al. · Frontiers in Pharmacology · 17
PDF
Role of cysteine-rich angiogenic inducer 61 in fibroblast-like synovial cell proliferation and invasion in rheumatoid arthritis
2014 · LI-GANG JIE, RUN-YUE HUANG, et al. · Molecular Medicine Reports · 17
PDF
China rheumatoid arthritis registry of patients with Chinese medicine (CERTAIN): Rationale, design, and baseline characteristics of the first 11,764 enrollees
2022 · Xun Gong, Wei-xiang Liu, et al. · Phytomedicine · 14
Chinese Herbal Formula, Huayu Tongbi Fang, Attenuates Inflammatory Proliferation of Rat Synoviocytes Induced by IL‐1β by Regulating Proliferation and Differentiation of T Lymphocytes
2020 · Hening Chen, Changzhi Wang, et al. · Evidence-based Complementary and Alternative Medicine · 11
PDF
The optimal treatment alternatives selection of integrated TCM and Western medicine based on dynamic conflict group decision-making models
2021 · Xiaoli Chu, Bingzhen Sun, et al. · Knowledge-Based Systems · 10
Efficacy and Safety of Ivarmacitinib, a Selective JAK1 Inhibitor, in Patients With Active Ankylosing Spondylitis: Results From an Adaptive Seamless Phase 2/3 Trial
2025 · Xu Liu, Liling Xu, et al. · Arthritis & Rheumatology · 7
PDF
The Impact of Traditional Chinese Medicine QingreHuoxue Treatment and the Combination of Methotrexate and Hydroxychloroquine on the Radiological Progression of Active Rheumatoid Arthritis: A 52-Week Follow-Up of a Randomized Controlled Clinical Study
2022 · Rouman Zhang, Xiao-Po Tang, et al. · Evidence-based Complementary and Alternative Medicine · 6
PDF
Personalized Medication for Chronic Diseases Using Multimodal Data‐Driven Chain‐of‐Decisions
2025 · Xiaoli Chu, Xiaoli Chu, et al. · Advanced Science · 5
PDF
Efficacy and Safety of CMAB008 Compared with Innovator Infliximab in Patients with Moderate-to-Severe Rheumatoid Arthritis Receiving Concomitant Methotrexate: A Randomized, Double-blind, Multi-center, Phase III Non-inferiority Study
2023 · Hua Ye, Shengyun Liu, et al. · Rheumatology and Therapy · 4
PDF
A quantitative and qualitative hybrid attributes based imbalanced group conflict analysis method and its application to evaluation of clinical therapeutic effect
2022 · Xiaoli Chu, Bingzhen Sun, et al. · Artificial Intelligence Review · 4
Trigonelline Shields Chondrocytes from Oxidative Damage in Osteoarthritis through Activation of the Keap1/Nrf2/ARE Signaling Pathway
2025 · Chunmei Jiang, Xiaohong He, et al. · Applied Biochemistry and Biotechnology · 3
Fri0415 Biosimilar Bat1406 Versus Adalimumab Therapy on Active Ankylosing Spondylitis: a Randomized, Double-blinded, Multicenter, Controlled Phase 3 Trial
2019 · Liudan Tu, Qiujing Wei, et al. · Annals of the Rheumatic Diseases · 3
Efficacy of Qingrehuoxue granule for bone protection in patients with active rheumatoid arthritis in China: The PRE-ERODE randomized controlled trial
2025 · Xun Gong, Jing Kang, et al. · Journal of Ethnopharmacology · 2
Observation of the bone destruction of Qingre Huoxue Decoction in the treatment of active rheumatoid arthritis based on MRI evaluation: study protocol for a multicenter, randomized, double-blinded, controlled clinical trial
2022 · Wei-xiang Liu, 达 李, et al. · Research Square
PDF
Works count: 26
Citation count: 2,461
H-index: 14
I10-index: 16
Year
Topic
Type